To the best of our knowledge, severe COVID-19 illnesses can trigger an IgA response in the bronchial mucosa.[10] Taken together, these results might suggest a link between the virus antigen-containing COVID-19 vaccine and an increase in anti-SARS-CoV-2 spike IgA. Here, CD79A is linked to COVID-19.